Skip Navigation

A Master Protocol for Biomarker-Based Treatment of AML The Beat AML Trial

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03013998

Study #:
STUDY00142713

Start Date:
Feb 27, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03013998

View Complete Trial Details & Eligibility at ClinicalTrials.gov